TSXV:GIGA - Post Discussion
Post by
SophiaBrown on Aug 17, 2021 3:33am
FSD Pharma has come a tremendous rise.
FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) recruited another consultant to do a more thorough evaluation of its principal pharmaceutical component, ultramicronized palmitoylethanolamide (PEA), or FSD201, in order to determine its present commercial viability.
Be the first to comment on this post